NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: PSKY 24.52%
Netflix Backs Out of the Warner Bros. Deal. 5 Reasons It's a Smart Move
NASDAQ: NGNE 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: PRAA 21.95%
NASDAQ: BWIN 21.95%
NASDAQ: ONMD 21.95%
